1-3 of 3
Bernard Bonnotte, M.D., Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Romiplostim for the Treatment of Adults with Primary Immune Thrombocytopenia (ITP) in Routine Clinical Practice in France – Interim Results From a Large Observational Study

Philippe Quittet, MD, Mohamed Hamidou, Bernard Bonnotte, M.D., Ph.D., Olivier Fain, Kerry Dillingham, Georg Kreuzbauer, MD
Journal: Blood
Blood (2012) 120 (21): 4643.
https://doi.org/10.1182/blood.V120.21.4643.4643
Published: 2012
Journal Articles

Cost Effectiviness of Rituximab Given At Fixed Dose (1000 mg on days 1 and 15) Compared to the Standard Regimen in adult's Immune Thrombocytopenia.

Matthieu Mahévas, Mikael Ebbo, Sylvain Audia, M.D., Ph.D., Bernard Bonnotte, M.D., Ph.D., Nicolas Schleinitz, MD, PhD, Corinne Haioun, MD, PhD, Medhi Khellaf, Bertrand Godeau, MD, Marc Michel IV
Journal: Blood
Blood (2012) 120 (21): 2157.
https://doi.org/10.1182/blood.V120.21.2157.2157
Published: 2012
Journal Articles

Failure of Rituximab in Immune Thrombocytopenia Is Associated with the Activation of Splenic CD8 T Cells

Sylvain Audia, M.D., Ph.D., Maxime Samson, M.D., Malika Trad, Ph.D., Nona Janikashvili, Ph.D., Denis Caillot, M.D., Laurent Martin, M.D., Ph.D., Bernard Lorcerie, M.D., Philippe Saas, Ph.D., Bernard Bonnotte, M.D., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 623.
https://doi.org/10.1182/blood.V120.21.623.623
Published: 2012